Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virus

Descripción del Articulo

The onset of the pandemic caused by the SARS-CoV-2 virus found the world unprepared. However, the reaction to it has been amazing. In just over a year since the virus was recognized, there are hundreds of vaccines in development, some of them already in use in many countries of the world. In this ma...

Descripción completa

Detalles Bibliográficos
Autores: Lanata-de las Casas, Claudio F., Ecker-Ledesma, Lucie, Cornejo-Cotos, Rubelio E., Celis-Albújar, Carlos R., Díaz-Parra, Carmen del Pilar, Ricalde-Ponce de León, Sheby A., Flores-Salmón, Omar, Ochoa Porras, Mayra, Peña-Peralta, Bia, Gil-Merino, Ana I.
Formato: artículo
Fecha de Publicación:2021
Institución:Fundación Instituto Hipólito Unanue
Repositorio:Diagnóstico
Lenguaje:español
OAI Identifier:oai:revistadiagnostico.fihu.org.pe:article/305
Enlace del recurso:https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/305
Nivel de acceso:acceso abierto
Materia:SARS-CoV2
COVID-19
coronavirus
vacunas
eficacia
efectividad
variantes de interés
variantes de preocupación
SARS-CoV-2
review
vaccines
efficacy
effectiveness
variants of interest
varians of concerns
id REVFIHU_afe1fbd466301176f792534a9795fd44
oai_identifier_str oai:revistadiagnostico.fihu.org.pe:article/305
network_acronym_str REVFIHU
network_name_str Diagnóstico
repository_id_str
spelling Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virusDesarrollo de las Vacunas contra el SARS-CoV-2 y las implicancias relacionadas a la aparición de las variantes del virusLanata-de las Casas, Claudio F. Ecker-Ledesma, Lucie Cornejo-Cotos, Rubelio E. Celis-Albújar, Carlos R. Díaz-Parra, Carmen del Pilar Ricalde-Ponce de León, Sheby A. Flores-Salmón, OmarOchoa Porras, MayraPeña-Peralta, BiaGil-Merino, Ana I. SARS-CoV2COVID-19coronavirusvacunaseficaciaefectividadvariantes de interésvariantes de preocupaciónSARS-CoV-2reviewCOVID-19coronavirusvaccinesefficacyeffectivenessvariants of interestvarians of concernsThe onset of the pandemic caused by the SARS-CoV-2 virus found the world unprepared. However, the reaction to it has been amazing. In just over a year since the virus was recognized, there are hundreds of vaccines in development, some of them already in use in many countries of the world. In this manuscript we review the current status of vaccine development, highlighting those that are under study to evaluate its efficacy or effectiveness. We also review the variants of interest and of concern of the SARS-CoV-2 virus detected until now and what is known about the efficacy of the vaccines against them.La aparición de la pandemia causada por el virus SARS-CoV-2 tomó desprevenido al mundo entero. Sin embargo, la reacción ha sido asombrosa. En poco más de un año de la aparición del virus, se cuenta con cientos de vacunas en desarrollo y varias de ellas vienen siendo aplicadas en casi todo el mundo. En este manuscrito revisamos el estado actual del desarrollo de las vacunas, resaltando aquéllas que cuentan con estudios de Fase III (eficacia) o IV (efectividad). Además, revisamos las variantes de interés y de preocupación del virus SARS-CoV-2 detectadas hasta el momento y qué se sabe sobre de la eficacia de las vacunas contra ellas.Fundación Instituto Hipólito Unanue2021-10-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmlhttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/30510.33734/diagnostico.v60i3.305Diagnóstico; Vol. 60 No. 3 (2021); 156-165Diagnostico; Vol. 60 Núm. 3 (2021); 156-1651018-28882709-795110.33734/diagnostico.v60i3reponame:Diagnósticoinstname:Fundación Instituto Hipólito Unanueinstacron:FIHUspahttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/305/308https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/305/323Derechos de autor 2021 Claudio F. Lanata-de las Casas; Lucie Ecker-Ledesma; Rubelio E. Cornejo-Cotos; Carlos R. Celis-Albújar; Carmen del Pilar Díaz-Parra; Sheby A. Ricalde-Ponce de León; Omar Flores-Salmón; Mayra Ochoa Porras; Bia Peña-Peralta; Ana I. Gil-Merinoinfo:eu-repo/semantics/openAccessoai:revistadiagnostico.fihu.org.pe:article/3052022-01-09T20:02:22Z
dc.title.none.fl_str_mv Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virus
Desarrollo de las Vacunas contra el SARS-CoV-2 y las implicancias relacionadas a la aparición de las variantes del virus
title Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virus
spellingShingle Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virus
Lanata-de las Casas, Claudio F.
SARS-CoV2
COVID-19
coronavirus
vacunas
eficacia
efectividad
variantes de interés
variantes de preocupación
SARS-CoV-2
review
COVID-19
coronavirus
vaccines
efficacy
effectiveness
variants of interest
varians of concerns
title_short Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virus
title_full Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virus
title_fullStr Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virus
title_full_unstemmed Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virus
title_sort Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virus
dc.creator.none.fl_str_mv Lanata-de las Casas, Claudio F.
Ecker-Ledesma, Lucie
Cornejo-Cotos, Rubelio E.
Celis-Albújar, Carlos R.
Díaz-Parra, Carmen del Pilar
Ricalde-Ponce de León, Sheby A.
Flores-Salmón, Omar
Ochoa Porras, Mayra
Peña-Peralta, Bia
Gil-Merino, Ana I.
author Lanata-de las Casas, Claudio F.
author_facet Lanata-de las Casas, Claudio F.
Ecker-Ledesma, Lucie
Cornejo-Cotos, Rubelio E.
Celis-Albújar, Carlos R.
Díaz-Parra, Carmen del Pilar
Ricalde-Ponce de León, Sheby A.
Flores-Salmón, Omar
Ochoa Porras, Mayra
Peña-Peralta, Bia
Gil-Merino, Ana I.
author_role author
author2 Ecker-Ledesma, Lucie
Cornejo-Cotos, Rubelio E.
Celis-Albújar, Carlos R.
Díaz-Parra, Carmen del Pilar
Ricalde-Ponce de León, Sheby A.
Flores-Salmón, Omar
Ochoa Porras, Mayra
Peña-Peralta, Bia
Gil-Merino, Ana I.
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv SARS-CoV2
COVID-19
coronavirus
vacunas
eficacia
efectividad
variantes de interés
variantes de preocupación
SARS-CoV-2
review
COVID-19
coronavirus
vaccines
efficacy
effectiveness
variants of interest
varians of concerns
topic SARS-CoV2
COVID-19
coronavirus
vacunas
eficacia
efectividad
variantes de interés
variantes de preocupación
SARS-CoV-2
review
COVID-19
coronavirus
vaccines
efficacy
effectiveness
variants of interest
varians of concerns
description The onset of the pandemic caused by the SARS-CoV-2 virus found the world unprepared. However, the reaction to it has been amazing. In just over a year since the virus was recognized, there are hundreds of vaccines in development, some of them already in use in many countries of the world. In this manuscript we review the current status of vaccine development, highlighting those that are under study to evaluate its efficacy or effectiveness. We also review the variants of interest and of concern of the SARS-CoV-2 virus detected until now and what is known about the efficacy of the vaccines against them.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-02
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/305
10.33734/diagnostico.v60i3.305
url https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/305
identifier_str_mv 10.33734/diagnostico.v60i3.305
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/305/308
https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/305/323
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
dc.publisher.none.fl_str_mv Fundación Instituto Hipólito Unanue
publisher.none.fl_str_mv Fundación Instituto Hipólito Unanue
dc.source.none.fl_str_mv Diagnóstico; Vol. 60 No. 3 (2021); 156-165
Diagnostico; Vol. 60 Núm. 3 (2021); 156-165
1018-2888
2709-7951
10.33734/diagnostico.v60i3
reponame:Diagnóstico
instname:Fundación Instituto Hipólito Unanue
instacron:FIHU
instname_str Fundación Instituto Hipólito Unanue
instacron_str FIHU
institution FIHU
reponame_str Diagnóstico
collection Diagnóstico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1847158631097696256
score 12.884794
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).